CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...

Could CRISPR Fix this Severe Childhood Brain Disorder?A technology that activates healthy genes reduced seizures in a mouse model of a severe genetic ...

Researchers have developed a new AI tool to help scientists plan gene-editing experiments. "CRISPR-GPT" can help generate ...